Matches in SemOpenAlex for { <https://semopenalex.org/work/W2368709534> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2368709534 endingPage "416" @default.
- W2368709534 startingPage "413" @default.
- W2368709534 abstract "The anti-CD20 peripheral B-cell depleting monoclonal antibody, rituximab, has been shown to be a safe and effective treatment for refractory pemphigus vulgaris (PV), a potentially fatal autoimmune blistering disease. We report a patient who developed skin nodules and arthralgias following successful treatment of refractory PV with rituximab. Clinical, serological and histological findings were consistent with a diagnosis of sarcoidosis. The nodules promptly responded to treatment with corticosteroids, and resolved without recurrence when the medication was tapered several months later. The temporal onset of sarcoidosis following treatment with rituximab and the eventual resolution, coupled with the remarkable similarities between the B-cell immunological environment expected in our patient during the post-rituximab period and the immunological environment described in patients with idiopathic sarcoidosis, strongly implicates exposure to rituximab as the trigger for sarcoidosis development in our patient. We propose that rituximab-induced sarcoidal granulomas may be a rare adverse effect of treatment with this medication, providing further support for an important role of B cells in the pathogenesis of sarcoidosis. With better understanding of the circumstances surrounding sarcoidosis development following rituximab administration, this medication could potentially be used to induce sarcoidosis in animal research models to study the immunopathogenesis of this disease." @default.
- W2368709534 created "2016-06-24" @default.
- W2368709534 creator A5060773989 @default.
- W2368709534 creator A5072527873 @default.
- W2368709534 date "2016-01-23" @default.
- W2368709534 modified "2023-10-18" @default.
- W2368709534 title "Sarcoidosis following successful treatment of pemphigus vulgaris with rituximab: a rituximab-induced reaction further supporting B-cell contribution to sarcoidosis pathogenesis?" @default.
- W2368709534 cites W1545405730 @default.
- W2368709534 cites W1988596351 @default.
- W2368709534 cites W2010282370 @default.
- W2368709534 cites W2069654222 @default.
- W2368709534 cites W2096463706 @default.
- W2368709534 cites W2120741582 @default.
- W2368709534 cites W2146514207 @default.
- W2368709534 cites W2151536078 @default.
- W2368709534 cites W4244164401 @default.
- W2368709534 doi "https://doi.org/10.1111/ced.12793" @default.
- W2368709534 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26800651" @default.
- W2368709534 hasPublicationYear "2016" @default.
- W2368709534 type Work @default.
- W2368709534 sameAs 2368709534 @default.
- W2368709534 citedByCount "21" @default.
- W2368709534 countsByYear W23687095342016 @default.
- W2368709534 countsByYear W23687095342017 @default.
- W2368709534 countsByYear W23687095342018 @default.
- W2368709534 countsByYear W23687095342019 @default.
- W2368709534 countsByYear W23687095342020 @default.
- W2368709534 countsByYear W23687095342021 @default.
- W2368709534 countsByYear W23687095342022 @default.
- W2368709534 countsByYear W23687095342023 @default.
- W2368709534 crossrefType "journal-article" @default.
- W2368709534 hasAuthorship W2368709534A5060773989 @default.
- W2368709534 hasAuthorship W2368709534A5072527873 @default.
- W2368709534 hasConcept C121332964 @default.
- W2368709534 hasConcept C142424586 @default.
- W2368709534 hasConcept C16005928 @default.
- W2368709534 hasConcept C18031839 @default.
- W2368709534 hasConcept C203014093 @default.
- W2368709534 hasConcept C2779338263 @default.
- W2368709534 hasConcept C2780653079 @default.
- W2368709534 hasConcept C2780942790 @default.
- W2368709534 hasConcept C2781301800 @default.
- W2368709534 hasConcept C2781313415 @default.
- W2368709534 hasConcept C2781327288 @default.
- W2368709534 hasConcept C71924100 @default.
- W2368709534 hasConcept C87355193 @default.
- W2368709534 hasConceptScore W2368709534C121332964 @default.
- W2368709534 hasConceptScore W2368709534C142424586 @default.
- W2368709534 hasConceptScore W2368709534C16005928 @default.
- W2368709534 hasConceptScore W2368709534C18031839 @default.
- W2368709534 hasConceptScore W2368709534C203014093 @default.
- W2368709534 hasConceptScore W2368709534C2779338263 @default.
- W2368709534 hasConceptScore W2368709534C2780653079 @default.
- W2368709534 hasConceptScore W2368709534C2780942790 @default.
- W2368709534 hasConceptScore W2368709534C2781301800 @default.
- W2368709534 hasConceptScore W2368709534C2781313415 @default.
- W2368709534 hasConceptScore W2368709534C2781327288 @default.
- W2368709534 hasConceptScore W2368709534C71924100 @default.
- W2368709534 hasConceptScore W2368709534C87355193 @default.
- W2368709534 hasIssue "4" @default.
- W2368709534 hasLocation W23687095341 @default.
- W2368709534 hasLocation W23687095342 @default.
- W2368709534 hasOpenAccess W2368709534 @default.
- W2368709534 hasPrimaryLocation W23687095341 @default.
- W2368709534 hasRelatedWork W2047535890 @default.
- W2368709534 hasRelatedWork W2076071554 @default.
- W2368709534 hasRelatedWork W2093516019 @default.
- W2368709534 hasRelatedWork W2135597948 @default.
- W2368709534 hasRelatedWork W2407110191 @default.
- W2368709534 hasRelatedWork W3030340422 @default.
- W2368709534 hasRelatedWork W3172387848 @default.
- W2368709534 hasRelatedWork W3176293470 @default.
- W2368709534 hasRelatedWork W4294706972 @default.
- W2368709534 hasRelatedWork W1862250341 @default.
- W2368709534 hasVolume "41" @default.
- W2368709534 isParatext "false" @default.
- W2368709534 isRetracted "false" @default.
- W2368709534 magId "2368709534" @default.
- W2368709534 workType "article" @default.